Work

Safety Profile of Venetoclax Monotherapy in Patients with Chronic Lymphocytic Leukemia

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.4395.4395

Authors: John F Seymour, Matthew S. Davids, Andrew W. Roberts, Michael Hallek, William G. Wierda, Peter Hillmen, John F. Gerecitano, Elisa Cerri, Jalaja Potluri, Su Young Kim, Todd Busman, Maria Verdugo, Rod A. Humerickhouse, Andrea Best, Monali Desai, Stephan Stilgenbauer

Institutions: Peter MacCallum Cancer Centre, Dana-Farber Cancer Institute, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, The University of Texas MD Anderson Cancer Center, St James's University Hospital, Memorial Sloan Kettering Cancer Center, AbbVie (United States), University Hospital Ulm

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590814247

FWCI: 1.208

Cites:

Cited by: 10

Related to: 10